GlassScriptPhysician profile
Martin Copeland
NPI 1215901038
$3,588.71
in general payments reported to CMS, 2019-2025
8 companies · $3,143 in 2025
The $3,143 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.50 · 2020: $72.52 · 2021: $24.11 · 2022: $95.59 · 2023: $98.56 · 2024: $75.19 · 2025: $3,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,170 · Food and Beverage: $647 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,170.23 |
| Food and Beverage | $646.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,537.97 | 2024-2025 | Cvi Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $715.08 | 2022-2025 | Precision 1, Air Optix Color, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $206.38 | 2019-2024 | Acuvue |
| Johnson & Johnson Surgical Vision, INC. | $36.88 | 2020 | |
| Bausch & Lomb Americas INC. | $35.90 | 2022 | |
| Quidel Corporation | $22.53 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $14.57 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Copeland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.